Skip to main content

Cardiogenic Shock clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

    Sorry, accepting new patients by invitation only

    The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.

    at UCLA

Last updated: